Skip to main content

Eduarda Godfired Nachtigall

Eduarda Godfired Nachtigall

Eduarda Godfired Nachtigall

Eduarda Godfired Nachtigall

Related news

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at VHIR, is the co-chair of the local organising committee. And Dr. Ariadna Laguna, principal investigator of the same group, is a scientific ambassador.

Related professionals

Joan Rey Cano

Joan Rey Cano

Research technician
Systemic Diseases
Read more
Moraima Jimenez Balarezo

Moraima Jimenez Balarezo

Senior researcher
Read more
Maria Eugenia Bustelo Almeida

Maria Eugenia Bustelo Almeida

Research technician
Childhood Cancer and Blood Disorders
Read more
Janet Illa Bernadí

Janet Illa Bernadí

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.